The global market for Short Sleep Syndrome Treatment was estimated to be worth US$ 8690 million in 2023 and is forecast to a readjusted size of US$ 15900 million by 2030 with a CAGR of 9.0% during the forecast period 2024-2030

Short Sleep Syndrome Treatment - Market

Short Sleep Syndrome is a sleep condition characterized by sleeping for fewer than six hours each night . Most adults need seven or more hours of sleep each night to feel rested in the morning.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Short Sleep Syndrome Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Short Sleep Syndrome Treatment by region & country, by Type, and by Application.

The Short Sleep Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Sleep Syndrome Treatment.

Market Segmentation

Scope of Short Sleep Syndrome Treatment - Market Report

Report Metric	Details
Report Name	Short Sleep Syndrome Treatment - Market
Forecasted market size in 2030	US$ 15900 million
CAGR	9.0%
Forecasted years	2024 - 2030
Segment by Type:	Benzodiazepines Nonbenzodiazepines Antidepressants Orexin Antagonist Melatonin Antagonist Other
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & co., Mylan N.V., Paratek pharmaceuticals, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon pharma Co. Ltd., Takeda Pharmaceuticals Company Ltd., Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Short Sleep Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Short Sleep Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Short Sleep Syndrome Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Short Sleep Syndrome Treatment - Market size in 2030?

Ans: The Short Sleep Syndrome Treatment - Market size in 2030 will be US$ 15900 million.

Who are the main players in the Short Sleep Syndrome Treatment - Market report?

Ans: The main players in the Short Sleep Syndrome Treatment - Market are Merck & co., Mylan N.V., Paratek pharmaceuticals, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon pharma Co. Ltd., Takeda Pharmaceuticals Company Ltd., Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.

What are the Application segmentation covered in the Short Sleep Syndrome Treatment - Market report?

Ans: The Applications covered in the Short Sleep Syndrome Treatment - Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Short Sleep Syndrome Treatment - Market report?

Ans: The Types covered in the Short Sleep Syndrome Treatment - Market report are Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Other

1 Market Overview

1.1 Short Sleep Syndrome Treatment Product Introduction

1.2 Global Short Sleep Syndrome Treatment Market Size Forecast

1.2.1 Global Short Sleep Syndrome Treatment Sales Value (2019-2030)

1.2.2 Global Short Sleep Syndrome Treatment Sales Volume (2019-2030)

1.2.3 Global Short Sleep Syndrome Treatment Sales Price (2019-2030)

1.3 Short Sleep Syndrome Treatment Market Trends & Drivers

1.3.1 Short Sleep Syndrome Treatment Industry Trends

1.3.2 Short Sleep Syndrome Treatment Market Drivers & Opportunity

1.3.3 Short Sleep Syndrome Treatment Market Challenges

1.3.4 Short Sleep Syndrome Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Short Sleep Syndrome Treatment Players Revenue Ranking (2023)

2.2 Global Short Sleep Syndrome Treatment Revenue by Company (2019-2024)

2.3 Global Short Sleep Syndrome Treatment Players Sales Volume Ranking (2023)

2.4 Global Short Sleep Syndrome Treatment Sales Volume by Company Players (2019-2024)

2.5 Global Short Sleep Syndrome Treatment Average Price by Company (2019-2024)

2.6 Key Manufacturers Short Sleep Syndrome Treatment Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Short Sleep Syndrome Treatment Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Short Sleep Syndrome Treatment

2.9 Short Sleep Syndrome Treatment Market Competitive Analysis

2.9.1 Short Sleep Syndrome Treatment Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Short Sleep Syndrome Treatment Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Sleep Syndrome Treatment as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Benzodiazepines

3.1.2 Nonbenzodiazepines

3.1.3 Antidepressants

3.1.4 Orexin Antagonist

3.1.5 Melatonin Antagonist

3.1.6 Other

3.2 Global Short Sleep Syndrome Treatment Sales Value by Type

3.2.1 Global Short Sleep Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Short Sleep Syndrome Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Short Sleep Syndrome Treatment Sales Value, by Type (%) (2019-2030)

3.3 Global Short Sleep Syndrome Treatment Sales Volume by Type

3.3.1 Global Short Sleep Syndrome Treatment Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Short Sleep Syndrome Treatment Sales Volume, by Type (2019-2030)

3.3.3 Global Short Sleep Syndrome Treatment Sales Volume, by Type (%) (2019-2030)

3.4 Global Short Sleep Syndrome Treatment Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Online Pharmacies

4.2 Global Short Sleep Syndrome Treatment Sales Value by Application

4.2.1 Global Short Sleep Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Short Sleep Syndrome Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Short Sleep Syndrome Treatment Sales Value, by Application (%) (2019-2030)

4.3 Global Short Sleep Syndrome Treatment Sales Volume by Application

4.3.1 Global Short Sleep Syndrome Treatment Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Short Sleep Syndrome Treatment Sales Volume, by Application (2019-2030)

4.3.3 Global Short Sleep Syndrome Treatment Sales Volume, by Application (%) (2019-2030)

4.4 Global Short Sleep Syndrome Treatment Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Short Sleep Syndrome Treatment Sales Value by Region

5.1.1 Global Short Sleep Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Short Sleep Syndrome Treatment Sales Value by Region (2019-2024)

5.1.3 Global Short Sleep Syndrome Treatment Sales Value by Region (2025-2030)

5.1.4 Global Short Sleep Syndrome Treatment Sales Value by Region (%), (2019-2030)

5.2 Global Short Sleep Syndrome Treatment Sales Volume by Region

5.2.1 Global Short Sleep Syndrome Treatment Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Short Sleep Syndrome Treatment Sales Volume by Region (2019-2024)

5.2.3 Global Short Sleep Syndrome Treatment Sales Volume by Region (2025-2030)

5.2.4 Global Short Sleep Syndrome Treatment Sales Volume by Region (%), (2019-2030)

5.3 Global Short Sleep Syndrome Treatment Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Short Sleep Syndrome Treatment Sales Value, 2019-2030

5.4.2 North America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Short Sleep Syndrome Treatment Sales Value, 2019-2030

5.5.2 Europe Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Short Sleep Syndrome Treatment Sales Value, 2019-2030

5.6.2 Asia Pacific Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Short Sleep Syndrome Treatment Sales Value, 2019-2030

5.7.2 South America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Short Sleep Syndrome Treatment Sales Value, 2019-2030

5.8.2 Middle East & Africa Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Short Sleep Syndrome Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Short Sleep Syndrome Treatment Sales Value

6.2.1 Key Countries/Regions Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.2.2 Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.3.2 United States Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.4.2 Europe Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.5.2 China Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.6.2 Japan Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.7.2 South Korea Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Short Sleep Syndrome Treatment Sales Value, 2019-2030

6.9.2 India Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck & co.

7.1.1 Merck & co. Company Information

7.1.2 Merck & co. Introduction and Business Overview

7.1.3 Merck & co. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck & co. Short Sleep Syndrome Treatment Product Offerings

7.1.5 Merck & co. Recent Development

7.2 Mylan N.V.

7.2.1 Mylan N.V. Company Information

7.2.2 Mylan N.V. Introduction and Business Overview

7.2.3 Mylan N.V. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Mylan N.V. Short Sleep Syndrome Treatment Product Offerings

7.2.5 Mylan N.V. Recent Development

7.3 Paratek pharmaceuticals

7.3.1 Paratek pharmaceuticals Company Information

7.3.2 Paratek pharmaceuticals Introduction and Business Overview

7.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Offerings

7.3.5 Paratek pharmaceuticals Recent Development

7.4 Pfizer Inc.

7.4.1 Pfizer Inc. Company Information

7.4.2 Pfizer Inc. Introduction and Business Overview

7.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Inc. Short Sleep Syndrome Treatment Product Offerings

7.4.5 Pfizer Inc. Recent Development

7.5 Sanofi S.A.

7.5.1 Sanofi S.A. Company Information

7.5.2 Sanofi S.A. Introduction and Business Overview

7.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Sanofi S.A. Short Sleep Syndrome Treatment Product Offerings

7.5.5 Sanofi S.A. Recent Development

7.6 Sumitomo Dainippon pharma Co. Ltd.

7.6.1 Sumitomo Dainippon pharma Co. Ltd. Company Information

7.6.2 Sumitomo Dainippon pharma Co. Ltd. Introduction and Business Overview

7.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Offerings

7.6.5 Sumitomo Dainippon pharma Co. Ltd. Recent Development

7.7 Takeda Pharmaceuticals Company Ltd.

7.7.1 Takeda Pharmaceuticals Company Ltd. Company Information

7.7.2 Takeda Pharmaceuticals Company Ltd. Introduction and Business Overview

7.7.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Offerings

7.7.5 Takeda Pharmaceuticals Company Ltd. Recent Development

7.8 Teva Pharmaceutical Industries Ltd.

7.8.1 Teva Pharmaceutical Industries Ltd. Company Information

7.8.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview

7.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Offerings

7.8.5 Teva Pharmaceutical Industries Ltd. Recent Development

7.9 Vanda Pharmaceuticals Inc.

7.9.1 Vanda Pharmaceuticals Inc. Company Information

7.9.2 Vanda Pharmaceuticals Inc. Introduction and Business Overview

7.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Offerings

7.9.5 Vanda Pharmaceuticals Inc. Recent Development

8 Industry Chain Analysis

8.1 Short Sleep Syndrome Treatment Industrial Chain

8.2 Short Sleep Syndrome Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Short Sleep Syndrome Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Short Sleep Syndrome Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Merck

Mylan N.V.

Paratek Pharmaceuticals

Pfizer Inc

Sanofi

Sumitomo Dainippon Pharma Co Ltd

Teva Pharmaceutical Industries Ltd

Vanda Pharmaceuticals, Inc.

Takeda Pharmaceuticals Company Ltd.

List of Tables

Table 1. Short Sleep Syndrome Treatment Market Trends

Table 2. Short Sleep Syndrome Treatment Market Drivers & Opportunity

Table 3. Short Sleep Syndrome Treatment Market Challenges

Table 4. Short Sleep Syndrome Treatment Market Restraints

Table 5. Global Short Sleep Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Short Sleep Syndrome Treatment Revenue Market Share by Company (2019-2024)

Table 7. Global Short Sleep Syndrome Treatment Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Short Sleep Syndrome Treatment Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Short Sleep Syndrome Treatment Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Short Sleep Syndrome Treatment Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Short Sleep Syndrome Treatment Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Short Sleep Syndrome Treatment

Table 13. Global Short Sleep Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Sleep Syndrome Treatment as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Short Sleep Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Short Sleep Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Short Sleep Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Short Sleep Syndrome Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Short Sleep Syndrome Treatment Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Short Sleep Syndrome Treatment Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Short Sleep Syndrome Treatment Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Short Sleep Syndrome Treatment Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Short Sleep Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Short Sleep Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Short Sleep Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Short Sleep Syndrome Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Short Sleep Syndrome Treatment Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Short Sleep Syndrome Treatment Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Short Sleep Syndrome Treatment Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Short Sleep Syndrome Treatment Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Short Sleep Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Short Sleep Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Short Sleep Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Short Sleep Syndrome Treatment Sales Value by Region (2019-2024) & (%)

Table 44. Global Short Sleep Syndrome Treatment Sales Value by Region (2025-2030) & (%)

Table 45. Global Short Sleep Syndrome Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Short Sleep Syndrome Treatment Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Short Sleep Syndrome Treatment Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Short Sleep Syndrome Treatment Sales Volume by Region (2019-2024) & (%)

Table 49. Global Short Sleep Syndrome Treatment Sales Volume by Region (2025-2030) & (%)

Table 50. Global Short Sleep Syndrome Treatment Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Short Sleep Syndrome Treatment Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume, (2025-2030) & (K Units)

Table 57. Merck & co. Company Information

Table 58. Merck & co. Introduction and Business Overview

Table 59. Merck & co. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Merck & co. Short Sleep Syndrome Treatment Product Offerings

Table 61. Merck & co. Recent Development

Table 62. Mylan N.V. Company Information

Table 63. Mylan N.V. Introduction and Business Overview

Table 64. Mylan N.V. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Mylan N.V. Short Sleep Syndrome Treatment Product Offerings

Table 66. Mylan N.V. Recent Development

Table 67. Paratek pharmaceuticals Company Information

Table 68. Paratek pharmaceuticals Introduction and Business Overview

Table 69. Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Offerings

Table 71. Paratek pharmaceuticals Recent Development

Table 72. Pfizer Inc. Company Information

Table 73. Pfizer Inc. Introduction and Business Overview

Table 74. Pfizer Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Pfizer Inc. Short Sleep Syndrome Treatment Product Offerings

Table 76. Pfizer Inc. Recent Development

Table 77. Sanofi S.A. Company Information

Table 78. Sanofi S.A. Introduction and Business Overview

Table 79. Sanofi S.A. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Sanofi S.A. Short Sleep Syndrome Treatment Product Offerings

Table 81. Sanofi S.A. Recent Development

Table 82. Sumitomo Dainippon pharma Co. Ltd. Company Information

Table 83. Sumitomo Dainippon pharma Co. Ltd. Introduction and Business Overview

Table 84. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Offerings

Table 86. Sumitomo Dainippon pharma Co. Ltd. Recent Development

Table 87. Takeda Pharmaceuticals Company Ltd. Company Information

Table 88. Takeda Pharmaceuticals Company Ltd. Introduction and Business Overview

Table 89. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Offerings

Table 91. Takeda Pharmaceuticals Company Ltd. Recent Development

Table 92. Teva Pharmaceutical Industries Ltd. Company Information

Table 93. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview

Table 94. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Offerings

Table 96. Teva Pharmaceutical Industries Ltd. Recent Development

Table 97. Vanda Pharmaceuticals Inc. Company Information

Table 98. Vanda Pharmaceuticals Inc. Introduction and Business Overview

Table 99. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Offerings

Table 101. Vanda Pharmaceuticals Inc. Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Short Sleep Syndrome Treatment Downstream Customers

Table 105. Short Sleep Syndrome Treatment Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Short Sleep Syndrome Treatment Product Picture

Figure 2. Global Short Sleep Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Short Sleep Syndrome Treatment Sales Volume (2019-2030) & (K Units)

Figure 5. Global Short Sleep Syndrome Treatment Sales Price (2019-2030) & (US$/Unit)

Figure 6. Short Sleep Syndrome Treatment Report Years Considered

Figure 7. Global Short Sleep Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Short Sleep Syndrome Treatment Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Short Sleep Syndrome Treatment Revenue in 2023

Figure 10. Short Sleep Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Benzodiazepines Picture

Figure 12. Nonbenzodiazepines Picture

Figure 13. Antidepressants Picture

Figure 14. Orexin Antagonist Picture

Figure 15. Melatonin Antagonist Picture

Figure 16. Other Picture

Figure 17. Global Short Sleep Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Short Sleep Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Short Sleep Syndrome Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 20. Global Short Sleep Syndrome Treatment Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Short Sleep Syndrome Treatment Price by Type (2019-2030) & (US$/Unit)

Figure 22. Product Picture of Hospital Pharmacies

Figure 23. Product Picture of Retail Pharmacies

Figure 24. Product Picture of Online Pharmacies

Figure 25. Global Short Sleep Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Short Sleep Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Short Sleep Syndrome Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 28. Global Short Sleep Syndrome Treatment Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Short Sleep Syndrome Treatment Price by Application (2019-2030) & (US$/Unit)

Figure 30. North America Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume (%), (2019-2030)

Figure 42. United States Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 48. China Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 50. China Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 60. India Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 62. India Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 63. Short Sleep Syndrome Treatment Industrial Chain

Figure 64. Short Sleep Syndrome Treatment Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Liquid Snore Stopper Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29F12885

Tue May 14 00:00:00 UTC 2024

Add to Cart

Circadian Rhythm Sleep Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31M953

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Circadian Rhythm Sleep Disorders Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18T13228

Fri Apr 19 00:00:00 UTC 2024

Add to Cart

Global Melatonin for Sleep Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14M12313

Wed Apr 10 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions